149 related articles for article (PubMed ID: 21209173)
21. [The antimicrobial activity of amikacin in comparison with three other aminoglycoside-antibiotics (author's transl)].
Jotzoff M
Med Klin; 1978 Jun; 73(24):914-7. PubMed ID: 661734
[TBL] [Abstract][Full Text] [Related]
22. Three species of Aeromonas (A. dhakensis, A. hydrophila and A. jandaei) isolated from freshwater crocodiles (Crocodylus siamensis) with pneumonia and septicemia.
Pu W; Guo G; Yang N; Li Q; Yin F; Wang P; Zheng J; Zeng J
Lett Appl Microbiol; 2019 Mar; 68(3):212-218. PubMed ID: 30609084
[TBL] [Abstract][Full Text] [Related]
23. Antibiotic resistance of Aeromonas hydrophila isolated from marketed fish and prawn of South India.
Vivekanandhan G; Savithamani K; Hatha AA; Lakshmanaperumalsamy P
Int J Food Microbiol; 2002 Jun; 76(1-2):165-8. PubMed ID: 12038573
[TBL] [Abstract][Full Text] [Related]
24. Aeromonas hydrophila--its implications in freshwater injuries.
Weber CA; Wertheimer SJ; Ognjan A
J Foot Ankle Surg; 1995; 34(5):442-6. PubMed ID: 8590878
[TBL] [Abstract][Full Text] [Related]
25. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
Bovelacci A; Montini G; Ramacciotti PG
Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
[TBL] [Abstract][Full Text] [Related]
26. In vitro activity of aminoglycosides against clinical isolates of Acinetobacter baumannii complex and other nonfermentative Gram-negative bacilli causing healthcare-associated bloodstream infections in Taiwan.
Liu JY; Wang FD; Ho MW; Lee CH; Liu JW; Wang JT; Sheng WH; Hseuh PR; Chang SC
J Microbiol Immunol Infect; 2016 Dec; 49(6):918-923. PubMed ID: 26364729
[TBL] [Abstract][Full Text] [Related]
27. Susceptibility of aerobic gram-negative bacilli to aminoglycosides. Effects of 45 months of amikacin as first-line aminoglycoside therapy.
Saavedra S; Vera D; Ramírez-Ronda CH
Am J Med; 1986 Jun; 80(6B):65-70. PubMed ID: 3014877
[TBL] [Abstract][Full Text] [Related]
28. Selective growth of resistant variants during incubation of Enterobacteriaceae with four aminoglycosides.
Nilsson L; Sörén L
J Antimicrob Chemother; 1986 Sep; 18(3):317-24. PubMed ID: 3771425
[TBL] [Abstract][Full Text] [Related]
29. Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa.
Marks MI; Hammerberg S; Greenstone G; Silver B
Antimicrob Agents Chemother; 1976 Sep; 10(3):399-401. PubMed ID: 825026
[TBL] [Abstract][Full Text] [Related]
30. Fulminant epiglottitis with evolution to necrotizing soft tissue infections and fasciitis due to Aeromonas hydrophila.
Apisarnthanarak A; Pheerapiboon P; Apisarnthanarak P; Kiratisin P; Mundy LM
Infection; 2008 Feb; 36(1):94-5. PubMed ID: 18165860
[No Abstract] [Full Text] [Related]
31. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
[No Abstract] [Full Text] [Related]
32. Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin.
Zhanel GG; Lawson CD; Zelenitsky S; Findlay B; Schweizer F; Adam H; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
Expert Rev Anti Infect Ther; 2012 Apr; 10(4):459-73. PubMed ID: 22512755
[TBL] [Abstract][Full Text] [Related]
33. Spectrum of extraintestinal disease due to Aeromonas species in tropical Queensland, Australia.
Kelly KA; Koehler JM; Ashdown LR
Clin Infect Dis; 1993 Apr; 16(4):574-9. PubMed ID: 8513068
[TBL] [Abstract][Full Text] [Related]
34. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
[TBL] [Abstract][Full Text] [Related]
35. Sensitivity of gentamicin-resistant gram-negative bacilli to tobramycin, netilmicin and amikacin as well as synergism with cephalosporins.
Kedzia WB; Mirska I
J Chemother; 1989 Jul; 1(4 Suppl):367-8. PubMed ID: 16312443
[No Abstract] [Full Text] [Related]
36. Antimicrobial resistance of Aeromonas hydrophila isolated from different food sources: A mini-review.
Stratev D; Odeyemi OA
J Infect Public Health; 2016; 9(5):535-44. PubMed ID: 26588876
[TBL] [Abstract][Full Text] [Related]
37. In vitro comparison of four aminoglycoside antibiotics: sisomicin, gentamicin, tobramycin, and BB-K8.
Levison ME; Kaye D
Antimicrob Agents Chemother; 1974 Jun; 5(6):667-9. PubMed ID: 15825423
[TBL] [Abstract][Full Text] [Related]
38. In vitro activity of plazomicin compared to other clinically relevant aminoglycosides in carbapenem-resistant Enterobacteriaceae.
Clark JA; Kulengowski B; Burgess DS
Diagn Microbiol Infect Dis; 2020 Oct; 98(2):115117. PubMed ID: 32755805
[TBL] [Abstract][Full Text] [Related]
39. A laboratory assessment of the activities of four aminoglycosides.
Schrire L; Robinson RG; Koornhof HJ
S Afr Med J; 1984 Jun; 65(23):922-4. PubMed ID: 6427946
[TBL] [Abstract][Full Text] [Related]
40. Staphylococcal resistance to aminoglycosides before and after introduction of amikacin in two teaching hospitals.
Hammerberg O; Elder D; Richardson H; Landis S
J Clin Microbiol; 1986 Oct; 24(4):629-32. PubMed ID: 3771751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
